Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

34.66 -0.06 (-0.17%)
Delayed Quote Updated: 3:53 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Indivior Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Indivior PLC (INDV) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Indivior PLC (INDV) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Rosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Indivior PLC (INDV) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Indivior PLC (INDV) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INDIVIOR PLC (NASDAQ: INDV) INVESTOR ALERT: Investors With Large Losses in Indivior PLC Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
News headline image
INDV Stock Earnings: Indivior Beats EPS, Beats Revenue for Q2 2024 ↗
INDV stock results show that Indivior beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Indivior PLC (INDV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Wells Fargo Posts Q2 Earnings, Joins Snowflake And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Indivior PLC (INDV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
S&P 500 Edges Higher; Indivior Shares Plummet ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Crude Oil Down 1%; Soligenix Shares Surge ↗
 
Via Benzinga
News headline image
What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday? ↗
Indivior lowers its profit forecast for 2024, discontinues sales of its schizophrenia drug Perseris, and announces job cuts, causing shares to plummet nearly 38%. The company updates its financial... 
Via Benzinga
News headline image
Why Is Soligenix (SNGX) Stock Up 296% Today? ↗
Soligenix stock is up on Tuesday with heavy trading of SNGX shares alongside positive clinical trial data from the company. 
Via InvestorPlace
News headline image
Dow Falls Over 50 Points; US Small Business Optimism Surges In June ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is Helen Of Troy (HELE) Stock Down 25% Today? ↗
Helen Of Troy stock is taking a beating on Tuesday as HELE investors react to lackluster earnings and lowered outlooks in its Q1 report. 
Via InvestorPlace
News headline image
Why Is Indivior (INDV) Stock Down 37% Today? ↗
Indivior stock is down on Tuesday as INDV investors react to a business update that includes lowered outlooks for Q2 and 2024. 
Via InvestorPlace
News headline image
Indivior Cuts 2024 Outlook, Joins BP And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning! 
Via InvestorPlace
News headline image
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Addiction Treatment Company, Indivior, Reports 12% YoY Growth For First Quarter Led By Sublocade Sales ↗
 
Via Benzinga
News headline image
INDV Stock Earnings: Indivior Misses EPS, Misses Revenue for Q1 2024 ↗
INDV stock results show that Indivior missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.